PPT-Renal Board Review – Part I

Author : faustina-dinatale | Published Date : 2015-09-26

April 4 2013 53yo man has a 3 week history of increasing weakness and anorexia He takes no medications On exam BP 13070 HR 80 without orthostatic changes No JVD

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Renal Board Review – Part I" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Renal Board Review – Part I: Transcript


April 4 2013 53yo man has a 3 week history of increasing weakness and anorexia He takes no medications On exam BP 13070 HR 80 without orthostatic changes No JVD rales or LE edema Labs BUN 12 . Case Scenario. Mr. . Abdulaziz. is 38-year-old Saudi who presented to the ER 2 days ago with a 1-month history of left-sided flank pain that radiates to the groin. The pain was sudden in onset, . colicky . Hemoglobinopathies. Miguel R. . Abboud. M.D.. Department of Pediatrics and Adolescent Medicine. American University of Beirut Medical Center . Sickle Cell Disease: Overview. Sickle cell . disease (SCD) . Jesse Courtier, MD . Assistant Clinical Professor of Radiology. UCSF Benioff Children’s Hopsital . Objectives. Objectives. Objectives. OUTLINE. Introduction: Diagnostic Radiology role in Radiation Oncology. Outline. Basics of transplantation. Benefits of transplantation. Immunosuppressive medications. Common post-transplant problems. Basics of Transplantation. Kidney transplantation is the most effective therapy for end-stage renal disease.. Excretion of . Aristolochic. Acid I in . the IPK . Page . 1. Mariana Babayeva MD, PhD. Touro College of Pharmacy,. New York, NY, USA. Aristolochic. Acid I. Page . 2. Compound extracted from plant . CONGENITAL RENAL DISEASE IMAGING. F.Hallaji. MD. radiologist. HYDRONEPHROSIS . Pregnancy in fetuses with unilateral or bilateral ANH should proceed to term. , except if complicated by severe . Stephanie Blackburn . OMS IV. OU-HCOM. Types of Skin Changes. Cutaneous manifestation of renal failure- the skin changes that nearly all renal patient have. Systemic diseases with prominent renal and cutaneous manifestations (. What do they do……………….?. IKA AGM. Dublin July 2014. Cardiac-Renal Centre. Cork University Hospital. Renal Services in 6 Hospital Groups. (*/^ – shared access contracted Units; [] planned Units). Renal . system (urinary . system) . Consists . of the kidneys, ureters, urinary bladder, and urethra. 1- Excretion of metabolic wastes. 2- Regulation of mineral and water balance, pH, …. 3- Release of renin that is important in ABP and blood volume regulation. Kidney/Renal Fibrosis Treatment Market Report published by value market research, it provides a comprehensive market analysis which includes market size, share, value, growth, trends during forecast period 2019-2025 along with strategic development of the key player with their market share. Further, the market has been bifurcated into sub-segments with regional and country market with in-depth analysis. View More @ https://www.valuemarketresearch.com/report/kidney-renal-fibrosis-treatment-market acute kidney injury AKI is a sudden and usually reversible loss of renal function which develops over days or weeks and is usually accompanied by a reduction in urine volume. . A rasied creatinine level can be due to acute, acute on chronic of chronic kidney disease.. By . Dr.Qutaiba. . Abdulkareem. . Qasim. 2020. Topics to be discussed. 1-Renal function :. Renal glomerular function . Renal tubular function . Water reabsorption: urinary concentration and dilution . Digital Laboratory. It’s best to view this in . Slide Show . mode, especially for the quizzes.. This module will take approximately 45 minutes to complete.. After completing this exercise, you should be able to (blue text in this module, tan text in subsequent kidney modules):. Tenofovir. . Disoproxil. . Fumarate. to . Tenofovir. . Alafenamide. Have Improved Renal and Bone Safety through 48 Weeks. Study GS-US-292-0112. Samir K. Gupta. 1. , Anton Pozniak. 2. , Jose Arribas.

Download Document

Here is the link to download the presentation.
"Renal Board Review – Part I"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents